Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

Abroad (travel likely)RecruitingPHASE2

Conditions

Retinitis Pigmentosa

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Associated Retina Consultants, Phoenix, Arizona, United States

    Contact: Study coordinator (Jillian Bollinger) · hello@doctrials.com · 480-999-5458
    Contact: Principal Investigator (Benjamin Bakall, MD, PhD)
  • California Retina Consultants, Bakersfield, California, United States

    Contact: Study coordinator (Brandy Plaat) · brandy.plaat@californiaretina.com · 805-568-7547
    Contact: Principal Investigator (Dante Pieramici, MD, FASRS)
  • Retina-Vitreous Associates Medical Group, Beverly Hills, California, United States

    Contact: Study coordinator (Clinical Trials Coordinator) · ejimenez@laretina.com · 310-289-2478
    Contact: Principal Investigator (David Liao, MD, PhD)
  • Gavin Herbert Eye Institute, UC Irvine, Irvine, California, United States

    Study coordinator · rmagallo@hs.uci.edu · 949-824-2020
    Contact: Principal Investigator (Mitul Mehta, MD, MS)
  • Retina Consultants Medical Group, Sacramento, California, United States

    Contact: Study coordinator (Joshua Greenwood) · greenwoodj@retinalmd.com · 916-974-9279
    Contact: Principal Investigator (David Telander, MD, PhD)
  • Bay Area Retina Associates, Walnut Creek, California, United States

    Contact: Study coordinator (Luis Monsalve) · lmonsalve@bayarearetina.com · 925-265-4146
    Contact: Principal Investigator (Roger Goldberg, MD)
  • Vitreo Retinal Associates, Gainesville, Florida, United States

    Contact: Study coordinator (Jing Zhang) · Jingzhang@vra-pa.com · 352-300-8412
    Contact: Principal Investigator (Christine Kay, MD)
  • Georgia Retina, Marietta, Georgia, United States

    Contact: Study coordinator (Blair Symington) · bsymington@garetina.com · 770-218-1888
    Contact: Principal Investigator (David Chin Yee, MD)
  • Illinois Retina Associates, Oak Park, Illinois, United States

    Contact: Study coordinator (Jamie Matute) · referrals@retinaconsultantsofamerica.com · 833-538-1216
    Contact: Principal Investigator (Mathew W MacCumber, MD, PhD)
  • NJRetina, Teaneck, New Jersey, United States

    Contact: Study coordinator (Benjamin Outten) · boutten@prismvisiongroup.com · 201-837-7300
    Contact: Principal Investigator (Luis Gonzalez, MD)
  • Long Island Vitreoretinal Consultants, Westbury, New York, United States

    Contact: Study coordinator (Ewelina Lokaj) · elokaj@vrcny.com · 516-466-0390
    Contact: Principal Investigator (Philip Ferrone, MD)
  • Retina Consultants of Texas: Bellaire Retina Center, Bellaire, Texas, United States

    Contact: Principal Investigator (Kenneth Fan, MD)
  • Retina Consultants of Texas: San Antonio, San Antonio, Texas, United States

    Contact: Study coordinator (Lydia Adams) · lydia.adams@retinaconsultantstexas.com · 210-903-1046
    Contact: Principal Investigator (Jeremiah Brown, MD)
  • The Retina Group of Washington, Fairfax, Virginia, United States

    Contact: Study coordinator (Katrina Arias) · karias@rgw.com · 703-698-9335
    Contact: Principal Investigator (Joshua Levinson, MD)
Study leads
  • Henry Klassen, MD, PhD

    Principal Investigator

    jCyte, Inc